BPMC - Financial Reports List - Blueprint Medicines Corporation - IntrinsicAlpha

Blueprint Medicines Corporation BPMC

Healthcare - Biotechnology - NASDAQ - US

$ 83.41

-0.602 %

$ 5.33 B

Market Cap

-78.67

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	103.41%	54.96%	60.80%
Annual Report	FY	10-K	2024-12-31	104.04%	86.77%	56.39%
Quarterly Report	Q3	8-K	2024-09-30	126.61%	57.91%	62.03%
Quarterly Report	Q2	8-K	2024-06-30	139.98%	62.35%	66.37%
Quarterly Report	Q1	8-K	2024-03-31	51.87%	168.80%	41.78%
Quarterly Report	Q4	8-K	2023-12-31	85.55%	30.08%	32.97%
Annual Report	FY	10-K	2023-12-31	22.22%	9.06%	11.47%
Quarterly Report	Q3	8-K	2023-09-30	-14.26%	-0.41%	-3.78%
Quarterly Report	Q2	8-K	2023-06-30	57.52%	16.85%	18.81%
Quarterly Report	Q1	8-K	2023-03-31	0.89%	-22.23%	-27.95%

1